CIBC World Markets

Atmus Filtration Technologies appoints Diego Donoso and Stuart A Taylor II to its Board of Directors

Retrieved on: 
Tuesday, March 19, 2024

Today, Atmus Filtration Technologies Inc. (NYSE: ATMU) (“Atmus”) announced the appointment of Diego Donoso and Stuart Taylor to its Board of Directors.

Key Points: 
  • Today, Atmus Filtration Technologies Inc. (NYSE: ATMU) (“Atmus”) announced the appointment of Diego Donoso and Stuart Taylor to its Board of Directors.
  • “I am pleased to have Diego and Stuart join the Atmus Board of Directors at a pivotal time for our company,” said Steph Disher, CEO of Atmus.
  • Mr. Donoso retired in April 2023 from Dow Inc., a materials science company, after a 30-year career with the company.
  • Stuart Taylor is the President of The Taylor Group LLC, a firm focused on creating and acquiring businesses in partnership with entrepreneurs.

AIMCo Announces Board of Directors Appointments

Retrieved on: 
Thursday, March 14, 2024

"On behalf of the members of the AIMCo Board, I would like to welcome Joel and Jason.

Key Points: 
  • "On behalf of the members of the AIMCo Board, I would like to welcome Joel and Jason.
  • AIMCo and the clients we serve will certainly benefit from the depth and breadth of experience and expertise that both will bring to their roles," said Dr. Ken Kroner, Vice Chair, AIMCo Board of Directors.
  • "The Board also wishes to express its gratitude to Sharon and Tom for their valuable contributions to the Board and for their steadfast dedication to AIMCo."
  • In accordance with the Alberta Investment Management Corporation Act, the Board of Directors is responsible for overseeing the management of the business and affairs of AIMCo.

Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer

Retrieved on: 
Monday, March 4, 2024

FOSTER CITY, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Matthew Plunkett, Ph.D., has been appointed as Chief Financial Officer of Apollomics.

Key Points: 
  • FOSTER CITY, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Matthew Plunkett, Ph.D., has been appointed as Chief Financial Officer of Apollomics.
  • We expect his financial strategy and business development expertise from working with development and commercial stage public companies to be a critical asset as we execute our clinical, regulatory and commercialization plans,” said Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics.
  • Prior to Aeovian, he was Chief Financial Officer at Imago Biosciences (acquired by Merck), where he led the efforts for the company’s $155 million Nasdaq initial public offering (IPO).
  • He was previously Chief Financial Officer at Nkarta Therapeutics, where he led the efforts for its $290 million Nasdaq IPO.

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Retrieved on: 
Friday, January 5, 2024

CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Allan Reine, M.D., as the Company’s Chief Financial Officer, effective January 17, 2024.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Allan Reine, M.D., as the Company’s Chief Financial Officer, effective January 17, 2024.
  • A seasoned financial executive with over twenty years’ experience in the biotechnology industry, Dr. Reine will be responsible for the company’s financing strategy and investor relations, and will oversee all financial operations as Prime Medicine begins its transition into a clinical company.
  • “I am delighted to welcome Allan to Prime Medicine.
  • He brings tremendous financial, operational and leadership experience in the life sciences space, as well as a proven track record developing and implementing multi-pronged strategies to finance a diverse pipeline and broad platform,” said Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine.

Canada's Gigaton-Scale Carbon Removal Project Developer, Deep Sky, Raises C$75M Series A Funding

Retrieved on: 
Thursday, November 16, 2023

MONTRÉAL, Nov. 16, 2023 /PRNewswire/ -- Deep Sky, a Montreal-based carbon removal project developer, today announced it has raised a total of $75M CAD in its Series A funding to support gigaton-scale carbon removal in Canada. The round includes conversion of its $17.7M seed note and $57.5M in new capital co-led by Brightspark Ventures and Whitecap Venture Partners, with major participation from Investissement Québec ($25M), as a mandate of the government of Quebec, OMERS Ventures, and Business Development Bank of Canada (BDC)'s Climate Tech Fund. The fresh capital will be used to begin planning and construction of its first commercial facility; grow the team; build corresponding carbon removal software for selling carbon credits; and fund its Alpha research facility, the world's first carbon removal research center.

Key Points: 
  • MONTRÉAL, Nov. 16, 2023 /PRNewswire/ -- Deep Sky , a Montreal-based carbon removal project developer, today announced it has raised a total of $75M CAD in its Series A funding to support gigaton-scale carbon removal in Canada.
  • Alongside the fresh capital, Deep Sky has added two prominent independent board members, Annesley Wallace and Sam Duboc.
  • We're committed to making Canada the carbon removal capital of the world and offering the highest quality carbon emission offsets."
  • Deep Sky is the world's first carbon removal project developer deploying the best carbon capture technology from around the world under one roof.

RecycLiCo Battery Materials Announces Results of Annual General Meeting of Shareholders

Retrieved on: 
Wednesday, November 1, 2023

SURREY, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V: AMY; OTC-US: AMYZF; FSE: ID4), a global leader in sustainable lithium-ion battery recycling technology, is pleased to report the results of its 2023 Annual General and Special Meeting.

Key Points: 
  • SURREY, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V: AMY; OTC-US: AMYZF; FSE: ID4), a global leader in sustainable lithium-ion battery recycling technology, is pleased to report the results of its 2023 Annual General and Special Meeting.
  • The motion to increase the board of directors to six members was not approved by shareholders.
  • Edward Skoda, who has served as a director of the Company since 2013, stepped down before the meeting and did not stand for re-election.
  • The Company’s board of directors (the “Board”) and management thank Mr. Skoda for his many years of service.

BCI Announces Closing of C$1.25 Billion Inaugural Bond Issuance

Retrieved on: 
Friday, October 27, 2023

Victoria, British Columbia, Canada, Oct. 27, 2023 (GLOBE NEWSWIRE) -- British Columbia Investment Management Corporation (BCI) issued C$1.25 billion senior unsecured notes, with a coupon of 4.90% and a maturity date of June 2, 2033.

Key Points: 
  • Victoria, British Columbia, Canada, Oct. 27, 2023 (GLOBE NEWSWIRE) -- British Columbia Investment Management Corporation (BCI) issued C$1.25 billion senior unsecured notes, with a coupon of 4.90% and a maturity date of June 2, 2033.
  • The notes settled on October 26, 2023 and are rated Aaa by Moody’s Investors Service, AAA by S&P Global Ratings, and AAA by DBRS Limited.
  • The offering was oversubscribed with over C$1.9 billion in orders from more than 50 global investors.
  • BCI accesses debt markets to support our clients’ investment objectives, providing broader portfolio diversification, an improved risk-adjusted investment profile, and enhanced liquidity.

Broker-Dealers Can Be Held Primarily Liable For Failing To Fulfill Their “Gatekeeping Responsibilities” Of Monitoring Their Clients’ Trading Activities

Retrieved on: 
Tuesday, October 3, 2023

The Court categorically rejected the defendants’ argument and held that where a broker-dealer fails to monitor its customers’ trading and is “reckless in not knowing that the trades being executed at their customers’ direction were manipulative" the broker can be held primarily liable.

Key Points: 
  • The Court categorically rejected the defendants’ argument and held that where a broker-dealer fails to monitor its customers’ trading and is “reckless in not knowing that the trades being executed at their customers’ direction were manipulative" the broker can be held primarily liable.
  • Brokers can no longer claim that they are not liable for their customers’ trading activities because they are only following their directions.
  • Warshaw Burstein, LLP is a full-service law firm in New York City, that since its formation 97 years ago, has distinguished itself through superior and cost-effective legal service and personalized client care and attention.
  • For more information, please visit www.wbny.com or visit us on LinkedIn, Facebook and Twitter: @warshawburstein.

PALLADIUM NAMES NEW PARTNERS

Retrieved on: 
Wednesday, September 13, 2023

NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Palladium Equity Partners, LLC, a middle market private equity buyout firm with over $3 billion in assets under management, today announced it has promoted three of its senior professionals -- Alexander J. Funk, Nancy A. Mitchell and Katherine A. Lehman -- to Partner, effective January 1, 2024. In addition, Dale O'Connell has been named Managing Director, Co-Head of Fundraising and Investor Relations, effective immediately.

Key Points: 
  • She also serves on the Board of Directors of Palladium portfolio company Envoy Global and Palladium Heritage portfolio company Southwest Strategies.
  • Prior to joining Palladium, Ms. Mitchell was a partner at O'Melveny & Myers, an international law firm.
  • Katherine A. Lehman joined Palladium in 2022 as Partner, Palladium Heritage after serving as a consultant in 2021.
  • Ms. Lehman, who leads the Palladium Heritage strategy, has been promoted to Partner of the Firm.

CHIP Mortgage Trust Issues $175 million of Medium Term Notes

Retrieved on: 
Friday, July 14, 2023

TORONTO, July 14, 2023 /CNW/ - CHIP Mortgage Trust ("CMT" or the "Trust") today announced that it has concluded the sale of $175 million of senior medium term notes (the "Notes").

Key Points: 
  • TORONTO, July 14, 2023 /CNW/ - CHIP Mortgage Trust ("CMT" or the "Trust") today announced that it has concluded the sale of $175 million of senior medium term notes (the "Notes").
  • The Notes have a coupon of 6.069%, are rated AAA (sf) by DBRS Limited and have an expected final payment date of November 14, 2028.
  • "We have closed another very successful issue of Notes by CMT," said Atul Chandra, Executive Vice President and Chief Financial Officer, HomeEquity Bank.
  • Medium term notes are, and will continue to be, a key source of funding for our rapidly growing reverse mortgage business."